American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort

Stephen Shiboski(University of California, San Francisco), Caroline H. Shiboski(University of California, San Francisco), Lindsey A. Criswell(University of California, San Francisco), Alan N. Baer(Johns Hopkins University), Stephen Challacombe(King's College London), Héctor Lanfranchi(Universidad de Buenos Aires), Morten Schiødt(Rigshospitalet), Hisanori Umehara(Kanazawa Medical University), Frederick B. Vivino(Penn Presbyterian Medical Center), Yang Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanhong Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Deborah Greenspan(University of California, San Francisco), Ana Maria Heidenreich(Universidad de Buenos Aires), P. Helin(Rigshospitalet), Bruce Kirkham(King's College London), K. Kitagawa(Kanazawa Medical University), G. Larkin(King's College London), Min Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Thomas M. Lietman(University of California, San Francisco), Jens Lindegaard(Glostrup Hospital), Nancy A. McNamara(University of California, San Francisco), Kevin L. Sack(University of California, San Francisco), Pepe Shirlaw(King's College London), S Sugai(Kanazawa Medical University), Cristina Vollenweider(Universidad de Buenos Aires), John P. Whitcher(University of California, San Francisco), Alex M. L. Wu(University of California, San Francisco), Shangzhu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wentao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), John S. Greenspan(University of California, San Francisco), T. E. Daniels(University of California, San Francisco)
Arthritis Care & Research
January 9, 2012
Cited by 1,347

Abstract

OBJECTIVE: We propose new classification criteria for Sjögren's syndrome (SS), which are needed considering the emergence of biologic agents as potential treatments and their associated comorbidity. These criteria target individuals with signs/symptoms suggestive of SS. METHODS: Criteria are based on expert opinion elicited using the nominal group technique and analyses of data from the Sjögren's International Collaborative Clinical Alliance. Preliminary criteria validation included comparisons with classifications based on the American–European Consensus Group (AECG) criteria, a model-based “gold standard”obtained from latent class analysis (LCA) of data from a range of diagnostic tests, and a comparison with cases and controls collected from sources external to the population used for criteria development. RESULTS: Validation results indicate high levels of sensitivity and specificity for the criteria. Case definition requires at least 2 of the following 3: 1) positive serum anti-SSA and/or anti-SSB or (positive rheumatoid factor and antinuclear antibody titer >1:320), 2) ocular staining score >3, or 3) presence of focal lymphocytic sialadenitis with a focus score >1 focus/4 mm2 in labial salivary gland biopsy samples. Observed agreement with the AECG criteria is high when these are applied using all objective tests. However, AECG classification based on allowable substitutions of symptoms for objective tests results in poor agreement with the proposed and LCA-derived classifications. CONCLUSION: These classification criteria developed from registry data collected using standardized measures are based on objective tests. Validation indicates improved classification performance relative to existing alternatives, making them more suitable for application in situations where misclassification may present health risks.


Related Papers

No related papers found

Powered by citation graph analysis